Elizabeth Balta - 15 Feb 2023 Form 4 Insider Report for Icosavax, Inc.

Role
General Counsel & Corp. Sec.
Signature
/s/ Elizabeth Bekiroglu
Issuer symbol
N/A
Transactions as of
15 Feb 2023
Net transactions value
$0
Form type
4
Filing time
17 Feb 2023, 18:13:07 UTC
Previous filing
15 Feb 2023
Next filing
01 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICVX Stock Option (Right to Buy) Award $0 +100,000 $0.000000 100,000 15 Feb 2023 Common Stock 100,000 $9.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option will vest on February 15, 2024, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the reporting person's continued service through the applicable vesting date.